title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
"AC Immune  ( ACIU )  Reports Q2 Loss, Lags Revenue Estimates",20220728T124511,https://www.zacks.com/stock/news/1959431/ac-immune-aciu-reports-q2-loss-lags-revenue-estimates,VRTX,0.213048,Neutral,0.102199
ANNX: Insider Buying Sends Annexon Stock Higher. But Does That Make It a Buy?,20220721T131546,https://stocknews.com/news/annx-vrtx-amgn-biib-insider-buying-sends-annexon-stock-higher-but-does-that-make/,VRTX,0.137671,Neutral,0.041143
Verve  ( VERV )  Up on Gene Editing Collaboration With Vertex,20220721T153400,https://www.zacks.com/stock/news/1955906/verve-verv-up-on-gene-editing-collaboration-with-vertex,VRTX,0.153961,Somewhat-Bullish,0.242751
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,VRTX,0.078099,Neutral,0.0
"Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset",20220722T125344,https://www.benzinga.com/general/biotech/22/07/28168177/daily-biotech-pulse-vistagens-anxiety-study-fails-silverback-to-merge-with-firm-developing-epipen,VRTX,0.159043,Neutral,0.045058
Biotech ETFs to Watch,20240311T211500,https://investingnews.com/daily/life-science-investing/biotech-investing/small-biotech-etfs/,VRTX,0.150592,Neutral,0.024391
"MacroGenics  ( NASDAQ:MGNX )  Upgraded to ""Buy"" at StockNews.com",20231109T095053,https://www.defenseworld.net/2023/11/09/macrogenics-nasdaqmgnx-upgraded-to-buy-at-stocknews-com.html,VRTX,0.056943,Neutral,0.035085
"ImmunoGen  ( IMGN )  Q1 Earnings Beat, Elahere Uptake Encouraging",20230501T150000,https://www.zacks.com/stock/news/2087582/immunogen-imgn-q1-earnings-beat-elahere-uptake-encouraging,VRTX,0.146692,Neutral,0.120221
GILD: 2 No-Brainer Biotech Stocks to Buy Right Now and 1 to Sell,20221018T203326,https://stocknews.com/news/gild-vrtx-rlmd-2-no-brainer-biotech-stocks-to-buy-right-now-and-1/,VRTX,0.242084,Somewhat-Bullish,0.194888
"This Analyst Boosts Price Target On Home Depot Following Strong Earnings, Plus Citigroup Slashes PT On This Stock By Over 60%",20220817T122748,https://www.benzinga.com/news/earnings/22/08/28533005/this-analyst-boosts-price-target-on-home-depot-following-strong-earnings-plus-citigroup-slashes-pt-,VRTX,0.229872,Neutral,-0.060459
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,VRTX,0.009551,Neutral,-0.048746
